FluroTech Ltd.

Recent News

  • FluroTech Submits Letter of Intention to the Drugs and Driving Committee

    Calgary, Alberta--(Newsfile Corp. - November 21, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce it has submitted its letter of intention to submit saliva-based roadside drug screening equipment for approval evaluation in early 2019 to the Drugs and Driving Committee (“DDC”), a committee within the Canadian Society of ...

    2018-11-21 10:00 AM ET
  • FluroTech Protects Its Technological Advantage with Patent Application

    Calgary, Alberta--(Newsfile Corp. - November 5, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce two recently-filed patent applications to which the Company holds exclusive, irrevocable rights for use in the cannabis industry. The patents include an international patent application filed October 31, 2018 ...

    2018-11-05 10:00 AM ET
  • FluroTech Appoints a New Chief Financial Officer and a Vice President of Business Development

    Calgary, Alberta--(Newsfile Corp. - November 1, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to introduce Mr. Curtis Smith as Chief Financial Officer taking over responsibilities from Mr. Gary Jones, who has been appointed Vice President of Business Development. Over the past three years Mr. Smith ...

    2018-11-01 9:00 AM ET
  • FluroTech Designs a Cocaine Test for Roadside Impairment Testing

    Calgary, Alberta--(Newsfile Corp. - October 23, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company

    2018-10-23 9:00 AM ET
  • FluroTech Applauds Canadian Cannabis Legalization and Provides Operational Update

    Calgary, Alberta--(Newsfile Corp. - October 19, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), developer of the CompleTest™ device for cannabis quality control, detection of the Company's biomarker and developer of a human saliva testing device that determines concentrations of ∆9-tetrahydrocannabinol ("THC"), methamphetamines and cocaine

    2018-10-19 9:00 AM ET
  • FluroTech Receives Good Manufacturing Practice Validation of the CompleTest(TM) Cannabinoid Assays for THCa and CBDa

    Calgary, Alberta--(Newsfile Corp. - September 25, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to report that preliminary Good Manufacturing Practice ("GMP") validation testing, done by the Drug Development and Innovation Center at the University of Alberta, of the CompleTest™ cannabinoid assays for THCa and CBDa were ...

    2018-09-25 9:00 AM ET
  • FluroTech Appoints Aurora's Former Chief Scientist Dr. MacMillan as Director of Scientific Research and Business Development

    Calgary, Alberta--(Newsfile Corp. - September 18, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce the appointment of Dr. Trevor MacMillan as Director of Scientific Research and Business Development. With prior industry experience at Aurora Cannabis Inc., Dr. MacMillan brings with him an impressive background ...

    2018-09-18 9:00 AM ET
  • FluroTech Refiles Interim Filings

    Calgary, Alberta--(Newsfile Corp. - September 14, 2018) - FluroTech Ltd. (TSXV: TEST) ("FluroTech" or the "Company") announces that, further to its prior press release on September 10, 2018, the Company has refiled its June 30, 2018 interim financial statements and amended Management's Discussion & Analysis for the same period. The ...

    2018-09-14 9:30 PM ET